Literature DB >> 19124456

Protein tyrosine kinase, syk: a key player in phagocytic cells.

Yumi Tohyama1, Hirohei Yamamura.   

Abstract

Spleen tyrosine kinase (Syk) is a non-receptor protein tyrosine kinase expressed in a wide range of haematopoietic cells. At the initial stage of investigation, main exploring was toward its functions in platelets and in classical immunoreceptor signalling. However, Syk has now been recognized as a key player in both innate and adaptive immunity. Especially, in phagocytosis, Syk plays essential roles in signalling evoked by various types of receptors such as FcgammaR, CR3, Dectin-1 and apoptotic cell-recognizing receptor. A variety of upstream immunoreceptor tyrosine-based activation motif-like molecules have been found and are still in the course of new studies. On the contrary, downstream effectors to explain diverse function of Syk are still under exploration. As its novel function, we propose the role of Syk in the regulation of alpha-tubulin acetylation. Further investigation on the effectors of Syk would give us more information in relation to therapeutic molecular targets.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19124456     DOI: 10.1093/jb/mvp001

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  30 in total

1.  Heme controls the regulation of protein tyrosine kinases Jak2 and Src.

Authors:  Xiao Yao; Parimaladevi Balamurugan; Aaron Arvey; Christina Leslie; Li Zhang
Journal:  Biochem Biophys Res Commun       Date:  2010-10-29       Impact factor: 3.575

2.  Jedi-1 and MEGF10 signal engulfment of apoptotic neurons through the tyrosine kinase Syk.

Authors:  Jami L Scheib; Chelsea S Sullivan; Bruce D Carter
Journal:  J Neurosci       Date:  2012-09-19       Impact factor: 6.167

3.  Spleen tyrosine kinase inhibition prevents tissue damage after ischemia-reperfusion.

Authors:  Omer Nuri Pamuk; Peter H Lapchak; Poonam Rani; Polly Pine; Jurandir J Dalle Lucca; George C Tsokos
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-06-03       Impact factor: 4.052

4.  NADPH oxidase 2 inhibitor diphenyleneiodonium enhances ROS-independent bacterial phagocytosis in murine macrophages via activation of the calcium-mediated p38 MAPK signaling pathway.

Authors:  Yuanfeng Zhu; Shijun Fan; Ning Wang; Xiaoli Chen; Yongjun Yang; Yongling Lu; Qian Chen; Jiang Zheng; Xin Liu
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

5.  Chlamydial infection of monocytes stimulates IL-1beta secretion through activation of the NLRP3 inflammasome.

Authors:  Ali A Abdul-Sater; Najwane Saïd-Sadier; Eduardo V Padilla; David M Ojcius
Journal:  Microbes Infect       Date:  2010-04-29       Impact factor: 2.700

6.  Immune complexes and late complement proteins trigger activation of Syk tyrosine kinase in human CD4(+) T cells.

Authors:  A K Chauhan; T L Moore
Journal:  Clin Exp Immunol       Date:  2012-02       Impact factor: 4.330

7.  SYK inhibitor entospletinib prevents ocular and skin GVHD in mice.

Authors:  Jonathan C Poe; Wei Jia; Julie A Di Paolo; Nancy J Reyes; Ji Yun Kim; Hsuan Su; John S Sundy; Adela R Cardones; Victor L Perez; Benny J Chen; Nelson J Chao; Diana M Cardona; Daniel R Saban; Stefanie Sarantopoulos
Journal:  JCI Insight       Date:  2018-10-04

8.  Copper Exposure Perturbs Brain Inflammatory Responses and Impairs Clearance of Amyloid-Beta.

Authors:  Masashi Kitazawa; Heng-Wei Hsu; Rodrigo Medeiros
Journal:  Toxicol Sci       Date:  2016-04-27       Impact factor: 4.849

9.  SYK interaction with ITGβ4 suppressed by Epstein-Barr virus LMP2A modulates migration and invasion of nasopharyngeal carcinoma cells.

Authors:  X Zhou; L Matskova; L-S Z Rathje; X Xiao; G Gish; M Werner; I Ignatyev; N Yu; W Zhao; F Tian; B Hou; Z Zhang; T Pawson; F Chen; I Ernberg
Journal:  Oncogene       Date:  2014-12-22       Impact factor: 9.867

10.  Syk mediates IL-17-induced CCL20 expression by targeting Act1-dependent K63-linked ubiquitination of TRAF6.

Authors:  Nan-Lin Wu; Duen-Yi Huang; Hsin-Ni Tsou; Ying-Cing Lin; Wan-Wan Lin
Journal:  J Invest Dermatol       Date:  2014-09-09       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.